Holman Division of Endocrinology, Diabetes & Metabolism Publications
Research conducted by NYU Langone’s Holman Division of Endocrinology, Diabetes, and Metabolism appears in leading academic and medical publications.
Defining prediabetes remission as a distinct prevention endpoint
Lancet. Diabetes & endocrinology. 2026 Feb ; 14:100-102
Endothelial Cell Regulation of Lipid Uptake During Feeding and Fasting
Arteriosclerosis, thrombosis, & vascular biology. 2026 Feb ; 46:e323501
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
Lancet. Diabetes & endocrinology. 2026 Feb ; 14:123-136
Joint Modeling of Longitudinal Biomarker and Survival Outcomes with the Presence of Competing Risk in the Nested Case-Control Studies with Application to the TEDDY Microbiome Dataset
Bioinformatics. 2026 Jan 22;
A Road Map to Understanding Cardiovascular Disease in Diabetes: From the AHA Strategically Focused Research Network in Cardiometabolic Health and Type 2 Diabetes
Circulation research. 2026 Jan 16; 138:e325798
Noc1 downregulation induces nucleolar stress and upregulates p53 isoforms, with a robust increase of the truncated p53E isoform in Drosophila wing discs
G3 : genes - genomes - genetics. 2026 Jan 14;
Personalized dietary feedback mediates the association of dietary self-monitoring adherence and weight loss: a post-hoc analysis of the Personal Diet Study
Journal of nutrition. 2026 Jan 13; 101364
Young Adult Diabetes Technology Use in Pediatric as Compared to Adult Practices
Endocrine practice. 2026 Jan ; 32:11-15